Figure 2

Inhibitory effect of bevacizumab on tumor growth in SCC1 (A) and H226 (B) xenograft models. Four groups of mice (n = 3 tumors per treatment group for each cell line) were treated with: IgG (control), bevacizumab 1 mg/kg, 5 mg/kg and 25 mg/kg. Bev, bevacizumab.